You are viewing: South Korea Structural Heart Devices Market analysis

The South Korea Structural Heart Devices Market was valued at $129.1 Million in 2024 and projected to reach to $206.6 Million by 2029, representing a compound annual growth rate of 9.9%. South Korea's structural heart devices market is positioned for sustained growth through 2029, supported by an aging population with rising cardiovascular disease prevalence and increasing healthcare spending.

South Korea Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Structural Heart Devices Market Trends and Insights

  • This expansion reflects South Korea's advanced healthcare infrastructure, aging population demographics, and increasing prevalence of structural heart conditions.
  • South Korea's market growth outpaces the global average, driven by rising adoption of minimally invasive procedures and strong government support for cardiovascular innovation. The structural heart devices sector in South Korea benefits from high healthcare spending, sophisticated medical technology adoption, and a well-established reimbursement framework.
  • South Korea's competitive advantage stems from its skilled medical workforce and investment in cardiac care centers.
  • Between 2024 and 2029, South Korea is expected to see accelerated demand for transcatheter aortic valve replacement (TAVR), mitral valve repair devices, and left atrial appendage (LAA) closure systems.
  • South Korea's market trajectory demonstrates the country's commitment to addressing cardiovascular disease through innovative device solutions..

Key Market Statistics

  • CAGR (2024-2029) 9.9% CAGR
  • Market Size, 2024 ~USD 129.1 Million
  • Forecast, 2029 ~USD 206.6 Million
  • Country South Korea

South Korea Structural Heart Devices Market Overview

Rapid Market Expansion :

South Korea's structural heart devices market is growing at 9.9% CAGR, outpacing the global average of 9.5%, driven by advanced healthcare infrastructure and increasing adoption of minimally invasive procedures.

Aging Population Dynamics :

South Korea's rapidly aging demographic profile is significantly increasing the prevalence of structural heart conditions, creating sustained demand for innovative device solutions and interventional treatments.

Healthcare Technology Leadership :

South Korea's position as a global healthcare technology hub, combined with strong government support for medical device innovation, accelerates market penetration of cutting-edge structural heart solutions.

Market Value Growth :

The market is projected to grow from USD 129.1 million in 2024 to USD 206.6 million by 2029, representing a 60% increase over the five-year forecast period.

South Korea Structural Heart Devices Market Dynamics

  • The country's advanced medical infrastructure and strong reimbursement policies create favorable conditions for device adoption.
  • Government initiatives promoting minimally invasive procedures and interventional cardiology are expected to drive market expansion. Key growth drivers include rising patient awareness, expanding catheter-based intervention capabilities, and growing physician adoption of transcatheter solutions.
  • South Korea's competitive healthcare market and emphasis on clinical outcomes will continue to attract major device manufacturers, fostering innovation and market competition that benefits patients and healthcare providers alike..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • South Korea's structural heart devices market will grow from USD 129.1 million (2024) to USD 206.6 million (2029) at a 9.9% CAGR.
    • South Korea's market growth rate exceeds the global average of 9.5%, reflecting strong regional demand and healthcare investment.
    • South Korea's aging population and rising cardiovascular disease prevalence are primary drivers of structural heart device adoption.
    • South Korea's advanced reimbursement policies and minimally invasive procedure adoption accelerate market expansion through 2029.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    South Korea Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    Target Audience

    • Medical Device Manufacturers : Manufacturers need South Korea-specific market data to develop localized product strategies, identify distribution channels, and understand regulatory requirements for structural heart device commercialization in this high-growth Asian market.
    • Healthcare Investors & PE Firms : Investors require detailed South Korea market analysis to evaluate investment opportunities in cardiovascular device companies, hospital networks, and healthcare technology firms benefiting from the market's 9.9% CAGR expansion.
    • Hospital & Healthcare Systems : Healthcare administrators need market insights to guide capital budgeting for structural heart device procurement, assess emerging technologies, and plan interventional cardiology program expansion across South Korean facilities.
    • Market Research & Strategy Consultants : Consultants require comprehensive South Korea market data to support client advisory work, competitive benchmarking, market entry strategies, and long-term business planning in the structural heart devices sector.
    • Regulatory & Compliance Professionals : Regulatory specialists need South Korea-specific market intelligence to navigate local approval processes, understand reimbursement frameworks, and ensure compliant market entry for structural heart device innovations.

    Reasons to Buy this Report

    • Market-Specific Growth Intelligence : Gain detailed insights into South Korea's 9.9% CAGR trajectory, understanding local market dynamics that outpace global averages and identifying high-growth opportunities specific to the Korean healthcare landscape.
    • Demographic & Clinical Insights : Access comprehensive analysis of South Korea's aging population trends and structural heart disease prevalence, enabling targeted market entry strategies and product positioning for this high-value segment.
    • Competitive Landscape Analysis : Understand South Korea's unique competitive environment, reimbursement policies, regulatory pathways, and key opinion leader networks essential for successful market penetration and partnership development.
    • Investment & Expansion Planning : Leverage five-year market projections (USD 129.1M to USD 206.6M) to inform capital allocation decisions, facility expansion plans, and resource deployment strategies in South Korea's growing healthcare sector.
    • Strategic Partnership Opportunities : Identify local distribution partners, hospital networks, and healthcare providers positioned to capitalize on South Korea's structural heart device market growth and establish sustainable competitive advantages.

    Frequently asked questions

    What is the current size of South Korea's structural heart devices market?

    South Korea's structural heart devices market was valued at USD 129.1 million in 2024 and is expected to reach USD 206.6 million by 2029.

    What is the projected growth rate for South Korea's structural heart devices market?

    South Korea's structural heart devices market is projected to grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2029.

    Why is South Korea's structural heart devices market growing faster than the global average?

    South Korea's market growth of 9.9% exceeds the global CAGR of 9.5% due to advanced healthcare infrastructure, an aging population, strong reimbursement policies, and high adoption rates of minimally invasive cardiac procedures.

    Which structural heart devices are most in demand in South Korea?

    South Korea shows strong demand for transcatheter aortic valve replacement (TAVR) devices, mitral valve repair systems, and left atrial appendage (LAA) closure devices, driven by minimally invasive procedure preferences.

    What factors are driving growth in South Korea's structural heart devices market?

    Key growth drivers in South Korea include an aging population, rising cardiovascular disease prevalence, advanced healthcare infrastructure, strong government support for medical innovation, and increasing adoption of catheter-based interventions.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status